GBA1 product catalyzes the hydrolysis of glucosylceramides into free ceramides and glucose in the lysosome, and it is associated with Gaucher’s disease type I and II (GD), Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) [8,9]. The gene discussed is GBA1; the disease is Parkinson disease.